批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2022/09/12 |
SUPPL-20(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2019/10/21 |
SUPPL-17(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2019/08/02 |
SUPPL-16(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2019/08/02 |
SUPPL-15(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2019/08/02 |
SUPPL-12(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2019/08/02 |
SUPPL-11(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2019/08/02 |
SUPPL-9(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2015/09/23 |
SUPPL-6(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2015/09/23 |
SUPPL-5(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2012/05/17 |
ORIG-1(原始申请) |
Approval |
|
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:CLOPIDOGREL BISULFATE 剂型/给药途径:TABLET;ORAL 规格:EQ 75MG BASE 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
020839 |
001 |
NDA |
PLAVIX |
CLOPIDOGREL BISULFATE |
TABLET;ORAL |
EQ 75MG BASE |
Prescription |
Yes |
No |
AB |
1997/11/17
|
SANOFI AVENTIS US |
076273 |
001 |
ANDA |
CLOPIDOGREL BISULFATE |
CLOPIDOGREL BISULFATE |
TABLET;ORAL |
EQ 75MG BASE |
Prescription |
No |
No |
AB |
2008/01/14
|
DR REDDYS |
076274 |
001 |
ANDA |
CLOPIDOGREL BISULFATE |
CLOPIDOGREL BISULFATE |
TABLET;ORAL |
EQ 75MG BASE |
Prescription |
No |
No |
AB |
2012/05/17
|
APOTEX INC |
076999 |
001 |
ANDA |
CLOPIDOGREL BISULFATE |
CLOPIDOGREL BISULFATE |
TABLET;ORAL |
EQ 75MG BASE |
Prescription |
No |
No |
AB |
2012/05/17
|
TEVA |
078004 |
001 |
ANDA |
CLOPIDOGREL BISULFATE |
CLOPIDOGREL BISULFATE |
TABLET;ORAL |
EQ 75MG BASE |
Prescription |
No |
No |
AB |
2012/05/17
|
ACME LABS |
090494 |
001 |
ANDA |
CLOPIDOGREL BISULFATE |
CLOPIDOGREL BISULFATE |
TABLET;ORAL |
EQ 75MG BASE |
Discontinued |
No |
No |
AB |
2012/05/17
|
SUN PHARM |
090540 |
001 |
ANDA |
CLOPIDOGREL BISULFATE |
CLOPIDOGREL BISULFATE |
TABLET;ORAL |
EQ 75MG BASE |
Prescription |
No |
No |
AB |
2012/05/17
|
AUROBINDO PHARMA LTD |
090844 |
001 |
ANDA |
CLOPIDOGREL BISULFATE |
CLOPIDOGREL BISULFATE |
TABLET;ORAL |
EQ 75MG BASE |
Prescription |
No |
No |
AB |
2012/05/17
|
TORRENT PHARMS LTD |
202925 |
001 |
ANDA |
CLOPIDOGREL BISULFATE |
CLOPIDOGREL BISULFATE |
TABLET;ORAL |
EQ 75MG BASE |
Discontinued |
No |
No |
AB |
2013/03/27
|
ACCORD HLTHCARE |
202928 |
001 |
ANDA |
CLOPIDOGREL BISULFATE |
CLOPIDOGREL BISULFATE |
TABLET;ORAL |
EQ 75MG BASE |
Prescription |
No |
No |
AB |
2014/02/10
|
MACLEODS PHARMS LTD |
203751 |
001 |
ANDA |
CLOPIDOGREL BISULFATE |
CLOPIDOGREL BISULFATE |
TABLET;ORAL |
EQ 75MG BASE |
Prescription |
No |
No |
AB |
2014/04/11
|
AMNEAL PHARMS |
204165 |
001 |
ANDA |
CLOPIDOGREL BISULFATE |
CLOPIDOGREL BISULFATE |
TABLET;ORAL |
EQ 75MG BASE |
Prescription |
No |
No |
AB |
2014/09/15
|
SCIEGEN PHARMS INC |
204359 |
001 |
ANDA |
CLOPIDOGREL BISULFATE |
CLOPIDOGREL BISULFATE |
TABLET;ORAL |
EQ 75MG BASE |
Prescription |
No |
No |
AB |
2017/02/02
|
RISING |
206376 |
001 |
ANDA |
CLOPIDOGREL BISULFATE |
CLOPIDOGREL BISULFATE |
TABLET;ORAL |
EQ 75MG BASE |
Prescription |
No |
No |
AB |
2018/05/07
|
PRINSTON INC |
213351 |
001 |
ANDA |
CLOPIDOGREL BISULFATE |
CLOPIDOGREL BISULFATE |
TABLET;ORAL |
EQ 75MG BASE |
Prescription |
No |
No |
AB |
2020/07/17
|
POLYGEN PHARMS |
205345 |
001 |
ANDA |
CLOPIDOGREL BISULFATE |
CLOPIDOGREL BISULFATE |
TABLET;ORAL |
EQ 75MG BASE |
Prescription |
No |
No |
AB |
2023/08/04
|
HETERO LABS LTD V |
203632 |
001 |
ANDA |
CLOPIDOGREL BISULFATE |
CLOPIDOGREL BISULFATE |
TABLET;ORAL |
EQ 75MG BASE |
Prescription |
No |
No |
AB |
2023/12/08
|
ALKEM LABS LTD |
091023 |
002 |
ANDA |
CLOPIDOGREL BISULFATE |
CLOPIDOGREL BISULFATE |
TABLET;ORAL |
EQ 75MG BASE |
Prescription |
No |
No |
AB |
2024/08/05
|
DR REDDYS LABS LTD |
215388 |
001 |
ANDA |
CLOPIDOGREL BISULFATE |
CLOPIDOGREL BISULFATE |
TABLET;ORAL |
EQ 75MG BASE |
Prescription |
No |
No |
AB |
2024/09/20
|
MSN |